GenVec and SAIC-Frederick to Develop HIV and Influenza Vaccines

November 12, 2009

SAIC-Frederick, Inc. (Frederick, MD), has signed a contract with GenVec, Inc. (Gaithersburg, MD), for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC, Frederick, MD).

SAIC-Frederick, Inc. (Frederick, MD), has signed a contract with GenVec, Inc. (Gaithersburg, MD), for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC, Frederick, MD).

Under the contract, the vaccines would comprise genetic material supplied by the VRC and adenoviral vectors supplied by GenVec.

Work under this contract will include generating HIV vaccine and universal flu vaccine candidates, process and assay development for manufacture of vaccine candidates for clinical testing, and continued support of the HIV vaccine candidates currently in clinical testing.

The Vaccine Research Center of the National Institute of Allergy and Infectious Diseases is part of the National Institutes of Health (NIH).